|Bid||42.18 x 2500|
|Ask||42.22 x 600|
|Day's Range||41.81 - 42.20|
|52 Week Range||37.20 - 45.58|
|PE Ratio (TTM)||47.25|
|Dividend & Yield||1.95 (4.62%)|
|1y Target Est||N/A|
Analysts expect to see a growth of ~11.4% in GlaxoSmithKline’s (GSK) 2Q17 revenues, which are expected to total nearly 7.3 billion British pounds.
For 2Q17, analysts estimate that GSK's revenues will rise ~11.4% to ~7.3 billion pounds, as compared to ~6.5 billion pounds for 2Q16.
We have three pharma giants that are set to report second-quarter results on Jul 26. Let's see how things are shaping up for this quarter.